Biomarkers in NHL

descriptionPublicationkeyboard_double_arrow_right Article 31 Mar 2011 English Publisher:Impact Journals, LLCJournal:Oncotarget, volume 2, pages 102-103 (eissn: 1949-2553,

Copyright policy )

Authors: Sami N, Malek;

doi: 10.18632/oncotarget.252

pmid: 21487162

pmc: PMC3260815

Biomarkers in NHL

- Summary
- Subjects
- Metrics

Abstract

Sami N. Malek * Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, 1500 E. Medical Center Drive, Ann Arbor, MI 48109 Received: April 1, 2011; Accepted: April 1, 2011; Published: April 1, 2011; Commentary On: He J, Wu J, Jiao Y, Wagner-Johnston N, Ambinder RF, Diaz LA, Kinzler KW, Vogelstein B. IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients. Oncotarget. 2011; 2(3): in this issue Correspondence: Sami N. Malek, e-mail: // // Abstract

Related Organizations

University of Michigan–Flint
United States
University of Michigan–Ann Arbor
United States

Keywords

Male, Lymphoma, Non-Hodgkin, Biomarkers, Tumor, Humans, Female

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average